A new study suggests that Proteus Digital Health’s sensor-embedded pills can improve adherence among Hepatitis C (HCV) patients who are at a high risk for nonadherence. The data — presented this week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results